Novo Nordisk's 2026 Forecast Now Runs From Up 2% to Down 2%

Novo Nordisk raised its 2026 forecast, called guidance, for sales and profit from running the business to a range of up 2% to down 2% on November 4, after third-quarter profit beat forecasts, Reuters reported. The range spans growth and decline. In February, it forecast a drop of up to 13%. In May, its worst case was 12%.